HELIUM, USP
Peakhelium, oxygen
NDAINHALATIONGAS
Approved
Jul 2013
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
2/8 — Basic
Drug data last refreshed 6h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HELIUM, USP is an inhaled gas mixture combining helium and oxygen administered via inhalation for respiratory support. The product functions as a respiratory therapeutic gas rather than a traditional pharmacological agent, with helium's lower density improving airflow dynamics in compromised airways. It is indicated for patients experiencing obstructive airway conditions where improved gas delivery is therapeutically beneficial.
Peak
Product is in peak commercial stage with moderate competitive pressure (30%), indicating stable market position but limited growth runway for expanding team headcount.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on HELIUM, USP offers stable career opportunities in a mature, niche respiratory market with limited but consistent demand. Roles are concentrated in commercial execution, medical affairs, and specialty sales rather than product innovation or expansion pipelines.
Field Sales RepresentativeRespiratory Specialty Sales
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.